Its long-standing relationship with Wellington enters a new era.

Centene and Exact Sciences are among the stocks with the deepest reductions. Second-quarter earnings were largely positive ...

Estate planning attorney Jenny Rozelle discusses which asset types are best for loved ones or charity and when trusts can ...

Last week's consumer and producer price data "revived [the] stickiness of inflation debate, he says. While jobless claims were subdued, a nonfarm payrolls report at the start of August showed the ...

OTTAWA--Foreign investors added modestly to their holdings of Canadian securities in June, the first purchases since the first month of the year, while Canadian investors picked up U.S. shares and non ...

Novo Nordisk shares (DK:NOVO.B) (NVO) rose 5% in opening New York trade. The American depository receipts however have plunged 37% this year amid increased competition for its weight-loss drugs as ...

Dow Jones Top Markets Headlines at 9 AM ET: Dow Futures Edge Lower Ahead of Trump-Zelensky Meeting | Global ... Stock futures inched lower ahead of President Trump's meeting with Ukrainian President ...

Dow Jones Top Company Headlines at 9 AM ET: Air Canada Halts Guidance as Flight Attendant Strike Continues | Soho ... Air Canada withdrew its financial targets Monday for the year as a strike by ...

Research consistently finds that investors, and their advisers, are too quick to sell winners and too slow to sell losers. The phenomenon has a name - the disposition effect - and it's highly studied ...

According to reports and a statement from Royal Caribbean (RCL), the passenger did not fall through the hole, but was nevertheless injured when a piece of acrylic glass broke off from the slide. Icon ...

Legend Biotech named Carlos Santos, an executive at AstraZeneca, as its new chief financial officer. At AstraZeneca, Santos served as CFO for U.S. oncology and before that, as acting area vice ...

Adaptive Biotechnologies said Monday that its strategic collaboration and licensing agreement with Genentech will be terminated, effective Feb. 9, 2026. Adaptive and Genentech, a unit of Roche, ...